Executive Vice President and Chief Strategy Officer
AbbVie, Inc.
Henry Gosebruch is Executive Vice President and Chief Strategy Officer at AbbVie, a global pharmaceutical company employing approximately 28,000 people and marketing medicines in more than 170 countries. As a member of AbbVie’s Executive Leadership Team, he is responsible for Corporate Strategy, Business Development & Acquisitions, Alliance Management and AbbVie Ventures. He reports to AbbVie’s CEO. Since joining AbbVie in December 2015 Henry has overseen more than a dozen M&A, partnering, collaboration and licensing transactions valued in excess of $10 billion.
Prior to his AbbVie appointment, Henry was Co-Head of J.P. Morgan’s North American M&A Group based in New York. He was a member of J.P. Morgan’s M&A group for more than 20 years where he worked on announced M&A transactions in excess of $375 billion in total value involving companies in more than 20 countries.
Henry is a frequent speaker on M&A panels and has been quoted by or appeared in articles by Bloomberg, CFO Magazine, the Financial Times, the New York Times and the Wall Street Journal.
Henry is a German citizen and fluent in German. He graduated magna cum laude from the Wharton School at the University of Pennsylvania. He is also a graduate of G100 Next Gen. Henry and his wife have three boys and live in Chicago.